New search | Conferencedetail
Print view

Neuromuscular Drug Development Summit

evvnt Platform / evvnt
Conference themes
Neuromuscular diseases are a huge unmet clinical need, with huge advances and excitement in the field now is the time combine forces and help accelerate development of truly curative neuromuscular therapeutics.

The inaugural Neuromuscular Drug Development Summit is industry's first dedicated discussion and networking forum focused on bringing together neuromuscular thought-leaders to share the latest scientific progress and address the current challenges drug developers are facing.
Professional congress organizer (PCO)
Neuromuscular Drug Development Summit

Speakers: Greg La Rosa Chief Scientific Officer, Senior Vice President, Rare Disease Research and Development Pfizer, Brian Kaspar Chief Scientific Officer Avexis, and more.

Enquiries and Registration:
Mr. Hanson Wade
General Medicine
Congress fees
Conference + 2 Workshops Early Bird Pricing: USD 3599.0, Conference + 2 Workshops Standard Pricing: USD 3899.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

European Health Forum GasteinAnästhesie in Entwicklungsländern e. V.FFG - 7. EU-RahmenprogrammHelix - Forschung & Beratung WiennewTreeÖsterreichisches Rotes KreuzSwiss Tropical and Public Health InstituteAMREF - African Medical and Research Foundation


Give us your professional opinion

Start survey

Start survey